Cladribine as an Exit Strategy in People with MS Over the Age of 50

Roos, IzanneSharmin, SifatMueller, JannisHorakova, DanaHavrdova, EvaOzakbas, SerkanKalincik, Tomas2025-12-302025-12-3020251352-45851477-0970https://hdl.handle.net/20.500.14365/8567eninfo:eu-repo/semantics/closedAccessCladribine as an Exit Strategy in People with MS Over the Age of 50Conference Object